NYSE ARCA | ETF
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 6.12% |
| CELC | Celcuity LLC | Healthcare | Biotechnology | 5.86% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 5.36% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 4.88% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 4.71% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 4.21% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 4.21% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 4.20% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 4.04% |
| 6160 | BeOne Medicines AG | Healthcare | Biotechnology | 4.04% |
| BAYN | Bayer AG NA | Healthcare | Drug Manufacturers - General | 3.97% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.93% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 3.92% |
| GMAB | Genmab A/S | Healthcare | Biotechnology | 3.89% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.87% |
| 4502 | Takeda Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 3.80% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 3.79% |
| IPN | Ipsen SA | Healthcare | Drug Manufacturers - Specialty & Generic | 3.76% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 3.71% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.69% |